This review summarizes the evidence for combination therapy with antiplatelet and anticoagulant drugs in patients with atrial fibrillation and acute coronary syndrome.
Answers are grounded in this paper and cite their sources.
Evidence summary on antithrombotic regimens in AF with ACS leaves open optimal combinations; randomized trials needed before practice change.
Patients being treated for atrial fibrillation may develop cardiovascular disease before or after the onset of their heart rhythm problem, and may require a combination of antiplatelet and anticoagulant drugs. This article describes the evidence for the combinations used to treat acute coronary syndrome in patients with atrial fibrillation.
No takes yet. Share an insight, caveat, or question.
Moatari et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: